CHU Nimes
Nîmes, 30029, France
NCT Number: NCT03628248
The investigators hypothesize that a primary embolization, 3-4 weeks before surgery, would allow development of vascular collaterality, in particular for the marginal artery which will ensure a better colonic perfusion.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Nîmes, 30029, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
proximal occlusion of the inferior mesenteric artery, before its divisional branches, by coils or plug 3-4 weeks prior to surgery.
Endovascular ligation of Inferior mesenteric artery
Time frame: Prior to start of surgery
Digital oxymeter (%)
Time frame: Prior to start of surgery
Average (mmHg)
Time frame: Prior to start of surgery
Rectal resistance index measured by Doppler
Time frame: 60 seconds after surgery
Digital oxymeter (%)
Time frame: 5 minutes after surgery
Digital oxymeter (%)
Time frame: 60 seconds after surgery
Average (mmHg)
Time frame: 5 minutes after surgery
Average (mmHg)
Time frame: 60 seconds after surgery
Rectal resistance index measured by Doppler
Time frame: 5 minutes after surgery
Rectal resistance index measured by Doppler
Time frame: Day 5 post-emoblization
Yes/No
Time frame: Hospital discharge (Day 7 after surgery)
Yes/No
Centre Hospitalier Universitaire de Nīmes
Other
Effect of Endovascular Inferior Mesenteric Artery Embolization on Colonic Perfusion Prior to Rectal Surgery for Rectal Tumor or Sigmoid Colon Surgery - A Single-center Feasibility Pilot Study.
Acronym: AMIREMBOL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07385898
Colonic Diseases, Colonic Neoplasms
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT05943041
Cancer, Colonic Diseases
Seoul, Gangnam-gu, South Korea
View Trial DetailsNCT05667259
Cancer, Rectum, Colorectal Neoplasms
Qina, Egypt
View Trial DetailsNCT03688906
Adenoma, Adenoma Colon
Huntsville, Alabama, United States
View Trial Details